About Hansoh Pharmaceutical Hansoh Pharmaceutical Group is one of Chinas leading biopharmaceutical companies, focused on the discovery, development, and commercialization of novel therapies in oncology, central nervous system diseases, and metabolic diseases
That number has been climbing for decades
GLP-1 medications target the metabolic effects of hormone changes, like cravings, blood sugar spikes, and belly fat, but they don't replace estrogen or treat symptoms like hot flashes
The body must convert it to bioactive methylcobalamin and adenosylcobalamin before cells can use it
Studies have also shown that these drugs interact with other parts of the body, potentially reducing the risk of health conditions such as kidney disease, cardiovascular diseases, and heart attacks